Biblio

Author Title [ Type

] Year

Filters: Author is Duval, Michel [Clear All Filters]

Journal Article

Beaufils C, Proulx C, Blincoe A, Teira P, Bittencourt H, Cellot S, Duval M, Morin M-P, De Bruycker JJacques, Couture J, et al. Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis. Front Med (Lausanne). 2023;10:1275927.

Ansari M, Uppugunduri CRao S, Ferrari-Lacraz S, Bittencourt H, Gumy-Pause F, Chalandon Y, Tiercy J-M, Schechter T, Gassas A, Doyle JD, et al. The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children. PLoS One. 2013;8(8):e72141.

Ceppi F, Duval M, Leclerc J-M, Laverdiere C, Delva Y-L, Cellot S, Teira P, Bittencourt H. Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy. PLoS One. 2016;11(9):e0160310.

Bonong PREnok, Buteau C, Duval M, Lacroix J, Laporte L, Tucci M, Robitaille N, Spinella PC, Cuvelier GDE, Lewis V, et al. Risk factors for post-transplant Epstein-Barr virus events in pediatric recipients of hematopoietic stem cell transplants. Pediatr Transplant. 2021:e14052.

Crisinel PAlex, Duval M, Crisinel DThuillard, Mallette B, Bellier N, Vachon M-F, Dedeken L, Rousseau C, Tapiero B, Ovetchkine P. Risk of cytomegalovirus infection and disease after umbilical cord blood transplantation in children. Can J Infect Dis Med Microbiol. 2013;24(1):e11-5.